deaths (OS)

mRCC - L1 - PDL1 positive metastatic/advanced RCC (mRCC) - 1st line (L1) mRCC - L1 - PDL1 positive

versus sunitinib
atezolizumab alone vs. sunitinib 1 -
atezolizumab plus bevacizumab vs. sunitinib 2 0.84 [0.62; 1.14], 1 RCT, I2=0%
inconclusive result